Epithelial ovarian cancer in Greece: A retrospective study of 1,791 patients by the hellenic cooperative oncology group (HeCOG)
dc.contributor.author | Pectasides, Dimitrios | en |
dc.contributor.author | Papaxoinis, G. | en |
dc.contributor.author | Fountzilas, George | en |
dc.contributor.author | Aravantinos, Gerasimos | en |
dc.contributor.author | Bamias, A. T. | en |
dc.contributor.author | Pavlidis, Nicholas | en |
dc.contributor.author | Kalofonos, H. P. | en |
dc.contributor.author | Timotheadou, E. | en |
dc.contributor.author | Samantas, E. | en |
dc.contributor.author | Briassoulis, E. Ch | en |
dc.contributor.author | Skarlos, Dimosthenis V. | en |
dc.contributor.author | Economopoulos, T. | en |
dc.contributor.author | Dimopoulos, M. A. | en |
dc.creator | Pectasides, Dimitrios | en |
dc.creator | Papaxoinis, G. | en |
dc.creator | Fountzilas, George | en |
dc.creator | Aravantinos, Gerasimos | en |
dc.creator | Bamias, A. T. | en |
dc.creator | Pavlidis, Nicholas | en |
dc.creator | Kalofonos, H. P. | en |
dc.creator | Timotheadou, E. | en |
dc.creator | Samantas, E. | en |
dc.creator | Briassoulis, E. Ch | en |
dc.creator | Skarlos, Dimosthenis V. | en |
dc.creator | Economopoulos, T. | en |
dc.creator | Dimopoulos, M. A. | en |
dc.date.accessioned | 2018-06-22T09:54:17Z | |
dc.date.available | 2018-06-22T09:54:17Z | |
dc.date.issued | 2009 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/42286 | |
dc.description.abstract | Background: The aim of this retrospective study was to present the epidemiological, pathological and clinical characteristics and treatment results of Greek women with epithelial ovarian cancer (EOC). Patients and Methods: From February 1976 to December 2006, 1,791 patients had been diagnosed, treated and followed up in the participating centers of the Hellenic Cooperative Oncology Group (HeCOG). Cox-regression analysis was carried out in order to identify possible prognostic factors. Results: The median age at diagnosis was 60 years. Seventy-five percent had a performance status (PS) of 0-1, 58.5% had a serous carcinoma, 36% had poorly differentiated tumors and 57% had International Federation of Gynecology and Obstetrics (FIGO) stage III disease. Approximately half of the patients had been subjected to a total abdominal hysterectomy, bilateral oophorectomy and omentectomy, and 80% of them had undergone optimal debulking surgery. Among 1,462 patients with advanced disease, 96% had received platinum-based chemotherapy, while platinum plus paclitaxel had been administered to two-thirds of them. Among 609 patients with known data for response, 34% had achieved a complete objective response (CR) and 30% a partial response (PR), resulting in an overall response rate (RR) of 64%. Performance status, FIGO stage and residual disease (RD) after cytoreductive surgery were the strongest prognostic factors for time-to-tumor progression (TTP) and for overall survival (OS), while age was found to be significant only for OS. The median TTP was 107 months (95% confidence interval (CI), 92-121 months) for patients with stages I-II, 17 months (95% CI, 15-18 months) for those with stages III-IV, 96 months (95% CI, 58-133 months) for patients without RD and 17 months (95% CI, 15-18 months) for those with RD. Median OS had not been reached for the patients with stages I-II, while it was 40 months (95% CI, 37-43 months) for those with stages III-IV, 141 months (95% CI, 103-179 months) for patients without RD and 42 months (95% CI, 39-45 months) for those with RD. Conclusion: There were no significant differences in patient characteristics or types of treatments administered in Greek women with EOC in comparison with those reported in the English literature. | en |
dc.language.iso | eng | en |
dc.source | Anticancer Research | en |
dc.subject | Greece | en |
dc.subject | Article | en |
dc.subject | Young adult | en |
dc.subject | Cisplatin | en |
dc.subject | Cyclophosphamide | en |
dc.subject | Doxorubicin | en |
dc.subject | Fluorouracil | en |
dc.subject | Human | en |
dc.subject | 80 and over | en |
dc.subject | Aged | en |
dc.subject | Humans | en |
dc.subject | Adult | en |
dc.subject | Cancer patient | en |
dc.subject | Female | en |
dc.subject | Major clinical study | en |
dc.subject | Middle aged | en |
dc.subject | Advanced cancer | en |
dc.subject | Cancer growth | en |
dc.subject | Cancer survival | en |
dc.subject | Carboplatin | en |
dc.subject | Ovarian neoplasms | en |
dc.subject | Ovary cancer | en |
dc.subject | Paclitaxel | en |
dc.subject | Platinum derivative | en |
dc.subject | Priority journal | en |
dc.subject | Retrospective studies | en |
dc.subject | Retrospective study | en |
dc.subject | Alopecia | en |
dc.subject | Anemia | en |
dc.subject | Antineoplastic combined chemotherapy protocols | en |
dc.subject | Febrile neutropenia | en |
dc.subject | Neurotoxicity | en |
dc.subject | Neutropenia | en |
dc.subject | Thrombocytopenia | en |
dc.subject | Prognosis | en |
dc.subject | Cancer staging | en |
dc.subject | Cytoreductive surgery | en |
dc.subject | Drug hypersensitivity | en |
dc.subject | Vomiting | en |
dc.subject | Tumor differentiation | en |
dc.subject | Prognostic factors | en |
dc.subject | Blood toxicity | en |
dc.subject | Nausea | en |
dc.subject | Treatment response | en |
dc.subject | Multiple cycle treatment | en |
dc.subject | Adolescent | en |
dc.subject | Ovariectomy | en |
dc.subject | Abdominal hysterectomy | en |
dc.subject | Epithelial ovarian cancer | en |
dc.subject | Omentectomy | en |
dc.subject | Registry | en |
dc.subject | Retrospective | en |
dc.title | Epithelial ovarian cancer in Greece: A retrospective study of 1,791 patients by the hellenic cooperative oncology group (HeCOG) | en |
dc.type | info:eu-repo/semantics/article | |
dc.description.volume | 29 | |
dc.description.issue | 2 | |
dc.description.startingpage | 745 | |
dc.description.endingpage | 751 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Pavlidis, Nicholas [0000-0002-2195-9961] | |
dc.contributor.orcid | Aravantinos, Gerasimos [0000-0002-2106-1713] | |
dc.contributor.orcid | Kalofonos, H. P. [0000-0002-3286-778X] | |
dc.gnosis.orcid | 0000-0002-2195-9961 | |
dc.gnosis.orcid | 0000-0002-2106-1713 | |
dc.gnosis.orcid | 0000-0002-3286-778X |
Αρχεία σε αυτό το τεκμήριο
Αρχεία | Μέγεθος | Τύπος | Προβολή |
---|---|---|---|
Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο. |